SecBot SecBot
8-K ·Filed Apr 28, 2026

ZBH

ZIMMER BIOMET HOLDINGS, INC.
BULLISH
Impact 8/10
Horizondays Processed6mo ago SEC0001193125-26-183411
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The strong EPS beat and raised guidance confirm improving margins and operational leverage. However, unchanged revenue guidance and modest organic growth (2.9% organic constant currency) suggest limited top-line acceleration. Watch for margin expansion and share repurchase execution to drive further EPS upside.

DirectionBullish
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$82.45
T+0 close · Apr 28, 2026 · via day close
Latest settled
+8.74%
T+60 · $89.65
Vs SPY
+5.02%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 28 $82.45entry
  2. T+1 · 7mo ago −2.92%α −2.91% · $80.04
  3. T+5 · 7mo ago +0.22%α −1.47% · $82.63
  4. T+20 · 6mo ago +0.08%α −5.37% · $82.52
  5. T+60 · 4mo ago +8.74%α +5.02% · $89.65

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Zimmer Biomet reported Q1 2026 adjusted EPS of $2.09, beating consensus of $1.86 by 12.4%, on revenue of $2.087B (+9.3% YoY reported). The company raised its full-year adjusted EPS guidance to $8.40-$8.55 from $8.30-$8.45, while maintaining revenue growth guidance of 2.5%-4.5% reported. The results reflect solid operational execution and ongoing share repurchases.

Key Financial Metrics

EPS
$2.09
est $1.86 · +12.4%
Revenue
$2.1B
+9.3% YoY
Rating
strong beat
Guidance
2.5% - 4.5%
raised
Free Cash Flow
$245.9M
Gross Margin
64.6%

Key Facts

  • Q1 2026 revenue of $2.087B, up 9.3% reported vs Q1 2025
  • Adjusted diluted EPS of $2.09, up 15.5% YoY and 12.4% above consensus $1.86
  • GAAP diluted EPS of $1.22, up 34.1% YoY
  • Full-year 2026 adjusted EPS guidance raised to $8.40-$8.55 (prior $8.30-$8.45)
  • Revenue guidance unchanged: reported change 2.5%-4.5%, organic constant currency 1.0%-3.0%
  • Operating cash flow of $359M, free cash flow of $246M in Q1
  • Repurchased $250M of shares during Q1 2026

Financial Impact

Adjusted EPS beat consensus by $0.23 (12.4%), and full-year EPS guidance midpoint increased by $0.10

revenueepscash flow

Risk Factors

  • Revenue guidance unchanged, indicating cautious top-line outlook
  • Goodwill impairment assessment still pending (not booked in Q1)
  • Go-to-market transformation may create near-term disruption
  • Tariff headwinds and integration of Paragon 28 remain risks

Market Snapshot

Exchange
NYSE
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
32% bullish (34 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-183411
Document: zbh-20260428.htm0001193125-26-183411
Document: 0001193125-26-183411-index-headers.html0001193125-26-183411
Document: 0001193125-26-183411-index.html0001193125-26-183411
Document: 0001193125-26-183411.txt0001193125-26-183411
8-K Data (Synthetic)0001193125-26-183411

Track record

17 reports on ZBH

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +3.00% at T+5 after the Oct 26, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 12, 20264d ago 8-K Neutral 3/10 Entry $103.21 Now $101.41 −1.74% settles Nov 20
  2. Nov 9, 20267d ago 424B5 Neutral 3/10 Entry $107.32 Now $101.41 −5.51% settles Nov 17
  3. Nov 9, 20267d ago 424B5 Neutral 3/10 Entry $107.32 Now $101.41 −5.51% settles Nov 17
  4. Nov 5, 202611d ago 424B5 Neutral 3/10 Entry $106.85 to $104.56 Now $101.41 −5.09% ▼ −2.14% −5.43% vs SPY
  5. Nov 5, 202611d ago 424B5 Neutral 2/10 Entry $106.85 to $104.56 Now $101.41 −5.09% ▼ −2.14% −5.43% vs SPY
  6. Nov 4, 202612d ago 8-K Neutral 5/10 Entry $110.15 to $107.47 Now $101.41 −7.93% ▼ −2.43% −1.52% vs SPY
  7. Oct 26, 202621d ago Institutional Cluster Bearish 4/10 Entry $97.44 to $94.52 Now $101.41 −4.07% ▲ +3.00% +1.74% vs SPY
  8. Oct 21, 202627d ago Court Ruling Bearish 6/10 Entry $98.81 to $97.47 Now $101.41 −2.63% ▲ +1.36% +2.06% vs SPY
  9. Sep 15, 20268w ago Insider Cluster Neutral 3/10 Entry $96.53 to $90.64 Now $101.41 +5.06% ▼ −6.10% −8.17% vs SPY
  10. Sep 2, 202610w ago Court Ruling Neutral 2/10 Entry $98.66 to $93.24 Now $101.41 +2.79% ▼ −5.49% −4.34% vs SPY
Showing 10 of 17

US Market Status

Market Closed · Opens in 6h 53m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 28, 2026